The Synergistic Antitumor Effect of Natural-Human TNF and Anticancer Drugs
Hiroshima Journal of Medical Sciences Volume 36 Issue 2
Page 157-161
published_at 1987-06
アクセス数 : 318 件
ダウンロード数 : 50 件
今月のアクセス数 : 4 件
今月のダウンロード数 : 0 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00049972
File |
HiroshimaJMedSci_36_157.pdf
638 KB
種類 :
fulltext
|
Title ( eng ) |
The Synergistic Antitumor Effect of Natural-Human TNF and Anticancer Drugs
|
Creator |
ITANO Satoshi
FUCHIMOTO Sadanori
ORITA Kunzo
|
Source Title |
Hiroshima Journal of Medical Sciences
|
Volume | 36 |
Issue | 2 |
Start Page | 157 |
End Page | 161 |
Journal Identifire |
[PISSN] 0018-2052
[EISSN] 2433-7668
[NCID] AA00664312
|
Abstract |
In the present report, we compared and discussed synergistic antitumor effects of natural-human tumor necrosis factor (n-TNF) which was derived from human acute lymphoblastic leukemia BALL-I cells and conventional anticancer drugs by using Lewis lung carcinoma which was transplanted on BDF1 mice. n-TNF and anticancer drugs were administered daily for 10 days. n-TNF showed antitumor effects which were equivalent to or stronger than MMC (1 mg/kg/day, i.v.), 5FU (5 mg/kg/day, i.v.), Adriamycin (1 mg/kg/day, i.v.), Actinomycin D (0.05 mg/kg/day, i.v.), Cyclophosphamide (10 mg/kg/day, i.v.) and OK-432 (0.5 KE/mouse/day, s.c.).
And synergistic antitumor effects were observed when n-TNF was administered with anticancer drugs, and the strong enforcement was obtained especially when it was combined with 5FU. |
Keywords |
Natural human TNF
Lymphokine
Anticancer drugs
Synergistic effect
|
NDC |
Medical sciences [ 490 ]
|
Language |
eng
|
Resource Type | departmental bulletin paper |
Publisher |
Hiroshima Journal Medical Press
|
Date of Issued | 1987-06 |
Publish Type | Version of Record |
Access Rights | open access |
Source Identifier |
[ISSN] 0018-2052
[NCID] AA00664312
[PMID] 3654267
|